Ledger.Open graph →
SEC Form D · filed October 17, 2023

Virax Biolabs Group Ltd

Offering
$2.1M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
London, United Kingdom
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Yair A. Erez · London, United KingdomDirectorEvan A. Norton · London, United KingdomDirectorMark A. Ternouth · London, United KingdomExec · DirectorJames A. Foster · London, United KingdomExec · DirectorNigel A. Mccracken · London, United KingdomExecLarry Marsh · NEW YORK, NYExec · DirectorBryan Sekino · NEW YORK, NYExec · DirectorMichael Doyle · NEW YORK, NYDirectorDan Sollof · NEW YORK, NYDirectorJason M. Davis · London, United KingdomExecNelson M. Haight · London, United KingdomDirectorKristen Yarbou · Dallas, TXDirectorMatthew Brennan · Dallas, TXExec · DirectorJake Bender · Dallas, TXDirectorCraig Mcneil · Dallas, TXExec · DirectorJason M. Davis · London, United KingdomExecNelson M. Haight · London, United KingdomDirectorNigel A. Mccracken · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗